ORA - Oxford University Research Archive

1 - 9 of 9

1

Conference

EXPERIENCE FROM A MULTI-DISCIPLINARY DEDICATED HAND OSTEOARTHRITIS CLINIC: THE ROLE OF CORTICOSTEROID INTRA-ARTICULAR INJECTION AS PART OF AN INDIVIDUALISED TREATMENT PROGRAMME

Watt, F, Kennedy, D, Seymour, M, et al.
2010-10-05

2

Conference

THROMBOCYTOSIS AS A PREDICTIVE AND PROGNOSTIC MARKER IN ADVANCED COLORECTAL CANCER (ACRC): RESULTS OF THE MRC COIN TRIAL EXPLORED

Maughan, T, Wilson, R, Seymour, M, et al.
2010-10-05

3

Conference

Mismatch Repair Testing in Colorectal Cancer - Is Less More?

Hutchins, G, Southward, K, Handley, K, et al.
2012-03-05

4

Conference

KRAS and BRAF Mutational Status can be Accurately Determined on Diagnostic Tissue Biopsies: An Analysis of Matched Biopsy and Resection Material from Patients with Colon Cancer in the NCRI FOxTROT trial

West, N, Hemmings, GJ, Richman, SD, et al.
2012-03-05

5

Conference

INTERMITTENT VS. CONTINUOUS OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN THE MRC COIN TRIAL IN ADVANCED COLORECTAL CANCER: UPDATED EFFICACY RESULTS, QUALITY OF LIFE AND POTENTIAL PREDICTIVE FACTORS

Adams, R, Wilson, R, Seymour, M, et al.
2010

6

Conference

Histopathological Downstaging of Colon Cancer Following Six Weeks of Pre-operative Chemotherapy: Early Results of the NCRI FOxTROT Trial

West, N, Tinkler-Hundal, E, Handley, K, et al.
2012-03-05

7

Conference

THE ADDITION OF CETUXIMAB TO OXALIPLATIN-FLUOROPYRIMIDINE CHEMOTHERAPY IN FIRST-LINE ADVANCED COLORECTAL CANCER IN THE MRC COIN TRIAL: IDENTIFICATION OF POTENTIALLY RESPONSIVE SUBSETS OF PATIENTS

Maughan, T, Adams, R, Smith, C, et al.
2010

8

Conference

THE IMPACT OF MILD RENAL IMPAIRMENT ON THE TOXICITY OF OXALIPLATIN AND FLUOROPYRIMIDINE REGIMENS: EXPERIENCE IN THE MRC COIN TRIAL

Madi, A, Wilson, R, Adams, R, et al.
2010

9

Conference

QCD

Nason, P, Webber, BR, Ward, D, et al.
1996

TO TOP